If the observed benefit of GLP-1 receptor agonists disappears or weakens meaningfully when compared with another contemporary metabolic therapy, then the story becomes less about a unique anticancer effect and more about broader metabolic optimization, comparator selection, or residual differences between treatment populations
GLP-1 Targeted Peptide Weight Loss Drugs Market, by Therapy Line, 20242034 Table 7: U.S
Clinical trial landscape in NASH
View Protocol Complete dosage protocol and reconstitution guide for TB-500 (10 mg Vial)
These changes can make the drug less effective, which is why FDA-approved drugs are often better, as the manufacturers must follow strict rules to make sure each dose is the same
These medications are administered via subcutaneous injection and are not absorbed through the gastrointestinal tract, meaning dietary components do not affect their bioavailability or metabolism in the way they might with oral medications
